Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Nevilledog

(53,815 posts)
Tue Feb 11, 2025, 04:37 PM Feb 11

Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.

https://www.nytimes.com/2024/11/19/magazine/ozempic-junk-food.html

No paywall link
https://archive.li/qvTDf

Trinian Taylor, a 52-year-old car dealer, pushed his cart through the aisles of a supermarket as I pretended not to follow him. It was a bright August day in Northern California, and I had come to the store to meet Emily Auerbach, a relationship manager at Mattson, a food-innovation firm that creates products for the country’s largest food and beverage companies: McDonald’s and White Castle, PepsiCo and Hostess. Auerbach was trying to understand the shopping behavior of Ozempic users, and Taylor was one of her case studies. She instructed me to stay as close as I could without influencing his route around the store. In her experience of shop-alongs, too much space, or taking photos, would be a red flag for the supermarket higher-ups, who might figure out we were not here to shop. “They’d be like, ‘You need to exit,’” she said.

Auerbach watched in silence as Taylor, who was earning $150 in exchange for being tailed, propelled his cart through snack aisles scattered with products from Mattson’s clients. He took us straight past the Doritos and the Hostess HoHos, without a side glance at the Oreos or the Cheetos. We rushed past the Pop-Tarts and the Hershey’s Kisses, the Lucky Charms and the Lay’s — they all barely registered.

Clumsily, close on his heels, Auerbach and I stumbled right into what has become, under the influence of the revolutionary new diet drug, Taylor’s happy place: the produce section. He inspected the goods. “I’m on all of these,” he told us. “I eat a lot of pineapple. A lot of pineapple, cucumber, ginger. Oh, a lot of ginger.”

Taylor, who lives in Hayward, Calif., used to nurse a sugar addiction, he said, but he can no longer stomach Hostess treats. A few days earlier, his daughter fed him some candy. “I just couldn’t,” he said. “It was so sweet it choked me.” His midnight snack used to be cereal, but now he stirs at night with strange urges. Salads. Chicken. He has sworn off canned sodas and fruit juices and infuses his water with lemon and cucumber. He dropped a heavy bag of lemons into the cart and sauntered over to the leafy vegetables. “I love Swiss chard,” he said. “I eat a lot of kale.”

*snip*
3 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back. (Original Post) Nevilledog Feb 11 OP
Chris Hayes' podcast NJCher Feb 11 #1
Billionaires make a lot of money on human cravings. Irish_Dem Feb 11 #3
date of podcast NJCher Feb 11 #2

NJCher

(39,202 posts)
1. Chris Hayes' podcast
Tue Feb 11, 2025, 04:50 PM
Feb 11

has a whole program on this topic. He interviewed Nick Reville; see a bit of his bio in this paragraph, which is an excerpt from the program description.

The amount of overdose deaths in the U.S. is staggering. And while addiction is a disease, there’s no specific medical treatment or cure for it. Our guest this week points out that weight loss drugs and GLP-1s, or glucagon-like peptide-1s, which are used to treat type 2 diabetes and obesity, can be effective for helping people reduce cravings and consumption of drugs, alcohol and compulsive behaviors like gambling. Nick Reville is the cofounder and executive director of the Center for Addiction Science, Policy, and Research (CASPR). He joins WITHpod to discuss how he found his way into this research area, lessons learned from other health crises, innovations geared towards eliminating addictions at a widescale level and more.

The exciting news is this is going to be an OTC drug worldwide next year. In the podcast, Chris was flabbergasted at this great news. It's really funny to listen to his reaction. Ya' gotta' love this guy.

I hope everyone reads the story and listens to this podcast. We have to reframe how we think of addiction, thanks to this drug, and think in terms of "cravings," which the glucagon-like peptide-1s can reduce--like to nothing.

So many of the problems we have in the U.S. are due to drugs. This news is a big, bright shining spot.

Irish_Dem

(65,575 posts)
3. Billionaires make a lot of money on human cravings.
Tue Feb 11, 2025, 04:58 PM
Feb 11

They won't like the cravings being cured.

Latest Discussions»General Discussion»Ozempic Could Crush the J...